All In Biotech

Free tool

FAERS Monitor: Gleolan

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 208630 or its brand name (Gleolan, Aminolevulinic Acid Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

161

Serious

83

52% of reports

Hospitalization

21

Death reported

7

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective46
  • hypotension31
  • vomiting11
  • inappropriate schedule of product administration9
  • cardiac arrest7
  • nausea7
  • photosensitivity reaction7
  • blood pressure decreased6
  • seizure6
  • atrial fibrillation5
  • hepatic function abnormal5
  • loss of consciousness5
  • off label use5
  • shock5
  • acute respiratory distress syndrome4

Reports by year received

View as table
YearReports
20131
20142
20152
20182
201927
202019
20216
202218
202324
202427
202519
202614

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,998 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
photosensitivity reactionSignal755.426.8322
acute respiratory distress syndromeSignal429.611.284
shockSignal528.412.0106
hypotensionSignal3120.214.7552
hepatic function abnormalSignal517.57.462
blood pressure decreasedSignal611.85.449
cardiac arrestSignal711.15.455
seizureSignal66.83.124
atrial fibrillationSignal56.72.819
inappropriate schedule of product administrationSignal96.53.537
loss of consciousnessSignal55.12.213
drug ineffectiveSignal464.63.6133
vomitingSignal113.11.714
nausea71.20.60
off label use50.70.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.